Annie Neild
Consejero General en FRAZIER LIFESCIENCES ACQUISITION CORPORATION .
Cargos activos de Annie Neild
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Consejero General | 01/03/2021 | - |
Historial de carrera de Annie Neild
Antiguos cargos conocidos de Annie Neild.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Consejero General | 01/01/2020 | 01/07/2020 |
Formación de Annie Neild.
| Yale University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Países Bajos | 2 |
Operativa
| General Counsel | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Annie Neild
- Experiencia
